-
Verdict due in Mexico trial over murders of Australia, US surfers
-
US suspending Microsoft from visa program: Vance
-
B2PRIME Welcomes Christina Barbash as Commercial Manager
-
Man City must 'stick together' during crisis, says Haaland
-
Russia forcing Kyiv into 'survival' mode before winter, mayor tells AFP
-
CAS opens hearing into Senegal AFCON title appeal
-
Closing arguments begin in Maradona death trial
-
UK police agree searches for ex-prince Andrew's homes 'unlawful': judge
-
UEFA president Ceferin to stand for re-election in 2027
-
After botched US execution, Christa Pike walking, mentally 'foggy': lawyer
-
Nearly 300,000 Nepalis at flood risk: study
-
'Stunned' Madrid mourns pensioner who sparked housing protests
-
Riyadh kindergarten hit by interception debris as Houthis say targeted airport
-
High school students turn out for new protests across France
-
Alex Bodi mizează, alături de CRIF, pe investiții transparente și pe prevenirea riguroasă a spălării banilor
-
Bid by Italy's Intesa bank to take over MPS gets boost
-
Gulf Labs, Part of Thailand’s $27 Billion GULF Group, Goes Live as an Injective Validator
-
Stablecoins Are Quietly Becoming Business Infrastructure, NOWPayments Data Shows
-
EU okay for winter despite 'historically low' gas stocks: operators
-
Oil surges, stocks sink as US reportedly eyes new Iran strikes
-
Rwanda to host F1 Grand Prix: sources close to both sides
-
Woman in botched US execution walking, mentally 'foggy': lawyer
-
EU top diplomat says bloc in favour of UN Lebanon peacekeepers' extension
-
Farhan hopes Pakistan's new combination takes off in Sri Lanka T20Is
-
Antonelli and Russell to run different Mercedes aero packages in Singapore
-
Teenager Andreeva seals China Open semi-final with Bartunkova
-
WTO hikes 2026 trade growth forecast on AI boom
-
Britain's Burnham says open to Germany joining warplane project
-
'I love that challenge': Hamilton prays for rain in Singapore
-
Kovac's tough love has Dortmund dreaming of title charge
-
G.Bissau moves towards postponement of December general election
-
China announces candidate for WHO chief
-
Verstappen out to settle 'unfinished business' at Singapore Grand Prix
-
South Korea test-fires its first homegrown hypersonic weapon: presidency
-
WhiteBIT Launches Bitcoin Lightning Network Support, Powered by Voltage
-
ONAR Advances Nasdaq Listing Preparation Following Advertise Purple Acquisition and Financing
-
Oil surges, stocks sink as US reportedly eyes fresh Iran strikes
-
Thailand opens extradition process for reporter sought by China
-
Anne Carson: modern takes on Greek classics
-
France struggles to wean social housing off gas
-
Canada's Anne Carson wins Nobel literature prize
-
Germany lifts GDP forecast as economy withstands Iran war
-
Ethiopia drones hit Eritrean troops in Tigray
-
Sri Lanka appoints Kusal Mendis as Test captain
-
Russian strike on buses kills 30 in frontline Ukrainian city
-
Norris confident McLaren can shine in Singapore
-
Thailand begins extradition process against Chinese journalist
-
Alex Bodi pushes ahead with expansion: ALIX LASERS showroom planned for Bucharest
-
Quarantine, unease and rumours: Russian city grapples with plague scare
-
Fossil fuels off COP31 agenda as global output keeps rising
US drug deaths decline, hinting at progress against opioid crisis
Drug overdose deaths in the United States declined last year for the first time since 2018, provisional data released Wednesday showed, suggesting tentative progress in combating the opioid epidemic even as experts cautioned against premature celebration.
There were an estimated 107,543 such deaths in the country in 2023, down three percent compared to the year before -- with the decline driven by a drop in fatalities associated with the synthetic opioid fentanyl, according to the Centers for Disease Control and Prevention (CDC).
"Today's data showing a decrease in drug overdoses over the 12-month period through December 2023 is heartening news for our nation and demonstrates we are making progress to prevent deaths from drug overdoses," said the CDC's chief medical officer Deb Houry.
But, she acknowledged, "this does not mean we have accomplished our mission," and much work remains to bring down the "staggering" annual death toll that remains well above 100,000.
- Opioid crisis -
America's opioid crisis has its roots in the 1990s with the aggressive marketing and over-prescription of opioid painkillers like OxyContin.
The current, decade-long surge in overdose deaths is largely driven by illicitly manufactured fentanyl -- primarily produced in China and smuggled into the United States through Mexico -- often mixed with stimulants including methamphetamine and cocaine.
More than a million American lives have been lost to drug overdoses over the past two decades.
This rate of mortality is far above peer countries, with only Scotland coming close. Factors including policies that emphasize criminalization and incarceration above drug treatment and harm-reduction are likely contributing, according to an analysis by nonprofit The Commonwealth Fund.
Joseph Friedman, a researcher at the University of California, Los Angeles, told AFP it was important to be cautious about over interpreting provisional figures, which could be revised in the final analysis.
"However, big picture, what is clear is that the death rate is currently leveling out compared to prior increases," he said.
"Many factors are likely playing a role here, including scaling up addiction treatment, making naloxone more available, as well as the spread of fentanyl virtually exhausting new places to take hold," Friedman added.
- Naloxone surge -
President Joe Biden's government has made expanding access to the opioid overdose reversal medicine naloxone a centerpiece of its policy to combat overdose deaths, making it available in schools, workplaces, airports and more.
Sold under the brand name Narcan and administered as a nasal spray, it is also available for over-the-counter purchase at pharmacies nationwide.
Friedman said it was important to note that part of the reason fentanyl deaths may be leveling out was simply because the drug had reached a saturation point in several states, even as it found new markets along the West Coast.
"Although the apparent leveling off from past increases in deaths is encouraging, there are no signs that the fundamental structural drivers of this crisis have changed considerably," he said.
And while deaths among white Americans have declined, they continue to rise among Black and Native Americans, highlighting the need to reduce barriers to services, and stabilize people exposed to fentanyl on safer opioids, he said.
D.Schaer--VB